Lv41
502 积分 2026-04-07 加入
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
1小时前
待确认
Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
1小时前
已完结
New drug therapies for hypertension
18天前
已完结
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
1个月前
已完结
ACHIEVE-1 Trial Investigators. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1个月前
已完结
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report
5个月前
已完结
皖公网安备34019202002308
